Optometry Forum: Extending Treatment Intervals in nAMD and DME

Faculty

Mark T. Dunbar, OD, FAAO

Director of Optometry

Bascom Palmer Eye Institute

UHealth - University of Miami Health System

Miami, FL

Nancy M. Holekamp, MD

Director, Retina Services

Pepose Vision Institute

St. Louis, MO

Agenda

Introduction

Mark T. Dunbar, OD

Introduction to the Port Delivery System (PDS) With Ranibizumab

Nancy M. Holekamp, MD

New Surgical Approaches That Extend Treatment Intervals in Retinal Disease: Defining the Role of Optometrists

Mark T. Dunbar, OD

A Closer Look at the Port Delivery System With Ranibizumab – Clinical Trials and Performance

Nancy M. Holekamp, MD

Case Presentation and Discussion

LIVE Question and Answer

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Review the challenges in managing and monitoring patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) regarding treatment frequency and adherence and the impact these have on outcomes.

• Recognize the benefits and limitations of long-acting delivery options for the treatment of nAMD and DME.

• Assess the clinical data on new surgical options that offer longer treatment intervals for patients with nAMD and DME.

• Summarize assessment and referral procedures that ensure that patients on treatments with extended intervals are seen regularly to allow for prompt interventions if needed.

Target Audience

The intended audience for this activity is optometrists and other health care professionals involved in managing patients with nAMD and/or DME.

For additional dates/times and information for this webinar series, click here.

Contact Us:

Email: Questions@VindicoCME.com